AI
HIMSS25
While AI technology shows promise for automating administrative tasks, Julie Frey, vice president of provider product at Wolters Kluwer, recommends caution in deploying AI, particularly generative AI, for clinical use cases.
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
HIMSS25
While decentralizing healthcare data using blockchain can potentially bolster organizations' cybersecurity, Matt Murren, CEO of True North ITG, cautions that quantum computing may one day crack blockchain's ciphers.
Also, TruScreen has secured a new distribution deal to reenter India.
Hal Wolf, president and CEO of HIMSS, provides highlights of the upcoming HIMSS25 Europe conference in Paris, including innovations within the European Union and discussions on how the healthcare market is evolving within the region.
It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
Video data is being used for quality assurance and improvement while AI provides insights and information which helps physicians learn more about surgery, say Transform Health Partners' Dr. Peter Billing and Medtronic's George Murgatroyd.
This follows the clearance for heart rate measurement on the FaceHeart mobile app in 2023.